|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-12-18
|
|
pubmed:abstractText |
Based on the efficacy of pegylated liposomal doxorubicin (PLD) in relapsed ovarian cancer, we are conducting a phase III study comparing carboplatin plus either paclitaxel or PLD as first-line therapy in advanced ovarian cancer. Because of limited phase I and II data on PLD plus carboplatin in this setting, we conducted an interim activity analysis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1423-0232
|
|
pubmed:author |
pubmed-author:BredaEE,
pubmed-author:CognettiFF,
pubmed-author:GebbiaVV,
pubmed-author:LorussoDD,
pubmed-author:MorabitoAA,
pubmed-author:PerroneFF,
pubmed-author:PignataSS,
pubmed-author:PisanoCC,
pubmed-author:SavareseAA,
pubmed-author:ScambiaGG,
pubmed-author:ScolloPP,
pubmed-author:SignorielloGG,
pubmed-author:SmithG FGF,
pubmed-author:Vernaglia LombardiAA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
76
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
49-54
|
|
pubmed:dateRevised |
2009-2-23
|
|
pubmed:meshHeading |
pubmed-meshheading:19039248-Adult,
pubmed-meshheading:19039248-Aged,
pubmed-meshheading:19039248-Antibiotics, Antineoplastic,
pubmed-meshheading:19039248-Antineoplastic Agents,
pubmed-meshheading:19039248-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19039248-Area Under Curve,
pubmed-meshheading:19039248-Carboplatin,
pubmed-meshheading:19039248-Doxorubicin,
pubmed-meshheading:19039248-Female,
pubmed-meshheading:19039248-Humans,
pubmed-meshheading:19039248-Middle Aged,
pubmed-meshheading:19039248-Neoplasm Staging,
pubmed-meshheading:19039248-Neoplasms, Glandular and Epithelial,
pubmed-meshheading:19039248-Ovarian Neoplasms,
pubmed-meshheading:19039248-Paclitaxel,
pubmed-meshheading:19039248-Polyethylene Glycols,
pubmed-meshheading:19039248-Survival Analysis,
pubmed-meshheading:19039248-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial.
|
|
pubmed:affiliation |
Oncologia Medica B, Istituto Nazionale Tumori, Naples, Italy. sandro.pignata@fondazionepascale.it
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Clinical Trial, Phase III
|
